Influenza and the use of oseltamivir in children
- PMID: 27489462
- PMCID: PMC4959743
- DOI: 10.5152/TurkPediatriArs.2016.2359
Influenza and the use of oseltamivir in children
Abstract
Influenza is an infectious disease which causes significant morbidity and mortality. In the USA, approximately 200 000 hospital admissions and 36 000 deaths occur annualy due to severe influenza infections. Although influenza often causes a simple respiratory infection, it sometimes causes disorders affecting several organs including the lung, heart, brain, liver and muscles or serious life-threatening primary viral or secondary bacterial pneumonia. Currently, oseltamivir is the most important and effective drug for severe influenza infections. Severe influenza infections can be controlled and related deaths may be prevented with initiation of this drug especially within first 2 days. Oseltamivir is usually well tolerated and its most commonly reported side effect is related with the gastrointestinal system. In conclusion, the course of influenza changes in a positive direction and the rates of complications and mortality significantly reduce in patients in whom oseltamivir treatment is initiated as soon as possible.
Keywords: Critically ill child; influenza; oseltamivir; pediatric intensive care.
Similar articles
-
Antiviral drugs in influenza: an adjunct to vaccination in some situations.Prescrire Int. 2006 Feb;15(81):21-30. Prescrire Int. 2006. PMID: 16548114
-
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13. Med Intensiva. 2012. PMID: 22245450 Spanish.
-
Oseltamivir: a review of its use in influenza.Drugs. 2001;61(2):263-83. doi: 10.2165/00003495-200161020-00011. Drugs. 2001. PMID: 11270942 Review.
-
[Influenza diagnostics in patient with leukemia suspicion].Pol Merkur Lekarski. 2006 Mar;20(117):341-4. Pol Merkur Lekarski. 2006. PMID: 16780271 Polish.
-
Oseltamivir for influenza infection in children: risks and benefits.Expert Rev Respir Med. 2016;10(1):79-87. doi: 10.1586/17476348.2016.1126182. Epub 2015 Dec 19. Expert Rev Respir Med. 2016. PMID: 26616633 Review.
Cited by
-
Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system.PLoS One. 2025 Feb 25;20(2):e0314970. doi: 10.1371/journal.pone.0314970. eCollection 2025. PLoS One. 2025. PMID: 39999160 Free PMC article.
References
-
- Subbarao K. Influenza viruses. In: Long SS, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases. 3th ed. Churchill; Livingstone: 2009. pp. 1130–8.
-
- Treanor JJ. Influenza Viruses, Including Avian Influenza and Swine Influenza. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. pp. 2265–88. http://dx.doi.org/10.1016/B978-0-443-06839-3.00165-X. - DOI
-
- Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733–45. http://dx.doi.org/10.1016/S0140-6736(03)14854-4. - DOI - PMC - PubMed
-
- Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, editors. Virology. 3rd ed. Philadelphia: Lippincott-Raven; 1996. pp. 1397–445.
-
- Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010;38:e91–e97. http://dx.doi.org/10.1097/CCM.0b013e3181c92eeb. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources